Autoimmune hemolytic anemia

From WikiMD.org
Jump to navigation Jump to search

Autoimmune Hemolytic Anemia (AIHA) (pronounced: aw-toh-ih-MYOON he-muh-LIT-ik uh-NEE-mee-uh) is a rare, serious blood condition.

Etymology

The term "Autoimmune Hemolytic Anemia" is derived from the following roots: "Auto" (Greek for self), "immune" (Latin for exempt), "Hemolytic" (Greek for blood + loosening), and "Anemia" (Greek for lack of blood).

Definition

Autoimmune Hemolytic Anemia is a group of disorders characterized by a malfunction of the immune system that produces autoantibodies, which attack red blood cells as if they were substances foreign to the body. This leads to a decrease in the number of red blood cells, a condition known as anemia, causing fatigue, weakness, and in severe cases, organ damage.

Types

There are two main types of AIHA: Warm autoimmune hemolytic anemia and Cold agglutinin disease. The classification is based on the temperature at which the autoantibodies are most active.

Symptoms

Common symptoms of AIHA include fatigue, weakness, pale skin, shortness of breath, and an increased heart rate. More severe symptoms may include dark urine, jaundice, and chest pain.

Causes

AIHA can be caused by or occur with another disorder, such as lupus, chronic lymphocytic leukemia, or non-Hodgkin's lymphoma, or it can occur alone. The exact cause of AIHA is unknown.

Diagnosis

Diagnosis of AIHA typically involves blood tests, including a complete blood count (CBC), direct antiglobulin test (DAT), and a reticulocyte count.

Treatment

Treatment for AIHA may include corticosteroids, immunosuppressive drugs, blood transfusions, and in severe cases, splenectomy.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski